Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A genome sequencing program for novel undiagnosed diseases.
Bloss CS, Zeeland AA, Topol SE, Darst BF, Boeldt DL, Erikson GA, Bethel KJ, Bjork RL, Friedman JR, Hwynn N, Patay BA, Pockros PJ, Scott ER, Simon RA, Williams GW, Schork NJ, Topol EJ, Torkamani A. Bloss CS, et al. Among authors: pockros pj. Genet Med. 2015 Dec;17(12):995-1001. doi: 10.1038/gim.2015.21. Epub 2015 Mar 19. Genet Med. 2015. PMID: 25790160 Free PMC article.
Mastocytosis: diverse presentations and outcomes.
Pauls JD, Brems J, Pockros PJ, Saven A, Wagner RL, Weber R, Metcalfe D, Christiansen SC. Pauls JD, et al. Among authors: pockros pj. Arch Intern Med. 1999 Feb 22;159(4):401-5. doi: 10.1001/archinte.159.4.401. Arch Intern Med. 1999. PMID: 10030315
Hematologic and oncologic diseases and the liver.
Singh MM, Pockros PJ. Singh MM, et al. Among authors: pockros pj. Clin Liver Dis. 2011 Feb;15(1):69-87. doi: 10.1016/j.cld.2010.09.013. Clin Liver Dis. 2011. PMID: 21111994 Review.
Novel therapeutic approaches for hepatitis C.
Au JS, Pockros PJ. Au JS, et al. Among authors: pockros pj. Clin Pharmacol Ther. 2014 Jan;95(1):78-88. doi: 10.1038/clpt.2013.206. Epub 2013 Oct 14. Clin Pharmacol Ther. 2014. PMID: 24126682 Review.
JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients.
Pockros PJ, Jensen D, Tsai N, Taylor R, Ramji A, Cooper C, Dickson R, Tice A, Kulkarni R, Vierling JM, Lou Munson M, Chen YC, Najera I, Thommes J; JUMP-C Investigators. Pockros PJ, et al. Hepatology. 2013 Aug;58(2):514-23. doi: 10.1002/hep.26275. Epub 2013 Jun 24. Hepatology. 2013. PMID: 23359491 Clinical Trial.
161 results